Product Description
The kit has been designed for the quantitative determination of B-type Natriuretic Peptide (BNP) in human serum or plasma. BNP measurement is used as an aid in the diagnosis and assessment of heart failure and cardiac dysfunction. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 800, MAGLUMI X8, and other MAGLUMI models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and MAGLUMI 4000.
| Brand | Snibe |
| Sample Type | Serum |
| Pack Size | 100T |
| CAT No. | 130206516M |
Advanced Diagnostic AccuracyMAGLUMI BNP (CLIA) discounts uncertainties in BNP assessment with its precise chemiluminescence technology, offering clinicians dependable results for cardiac evaluations. Its new and portable formulation streamlines sample handling in busy hospital and laboratory environments, improving workflows and patient turnaround time.
Convenient Integration into Hospital and Lab SettingsThe reagent is engineered for immediate application in laboratories and hospitals, requiring no installation in wall mounts or permanent fixtures. Its seamless compatibility with standard CLIA analyzers ensures quick setup and simple usage, making it a practical solution for medical institutions in need of rapid biomarker diagnostics.
FAQ's of MAGLUMI BNP (CLIA):
Q: How is the MAGLUMI BNP (CLIA) reagent used in hospitals and labs?
A: The MAGLUMI BNP (CLIA) reagent is directly applied within CLIA analyzers found in hospital and laboratory settings. It facilitates the quantitative detection of B-type Natriuretic Peptide, aiding in cardiac function assessment without requiring wall mounting or generating noise.Q: What are the benefits of using this reagent over traditional BNP testing methods?
A: This reagent offers high sensitivity, specific detection, and rapid results. Its chemiluminescence technology provides accurate diagnostics, supporting timely clinical decisions in acute healthcare settings.Q: When is it recommended to perform BNP testing with this reagent?
A: BNP testing with MAGLUMI BNP (CLIA) is recommended when heart failure or cardiac dysfunction is suspected, during patient admissions for cardiac-related symptoms, and for ongoing monitoring of diagnosed cardiac patients.Q: Where can the MAGLUMI BNP (CLIA) reagent be sourced in India?
A: The reagent is available across India through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers who specialize in laboratory diagnostic products.Q: What is the general process for using the MAGLUMI BNP (CLIA) reagent?
A: Once loaded into a compatible CLIA analyzer, the instrument's automated process mixes the reagent with patient samples, measures BNP levels, and delivers precise, actionable results swiftly for clinical interpretation.Q: Is the reagent portable and suitable for temporary setups or field laboratories?
A: Yes, the MAGLUMI BNP (CLIA) reagent is portable, making it an excellent choice for use in both established hospital labs and temporary or mobile laboratory environments.